Detalles de la búsqueda
1.
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20142570
Resultados
1 -
1
de 1
1
Próxima >
>>